Site search
Correspondence address
310 Mira Street, Stavropol, Russia, 355017
Tel
+7 865 2352511, +7 865 2353229.
E-mail
medvestnik@stgmu.ru
The journal is included into The list of leading scientific periodicals.
The journal is included into VINITI database and is registered in Electronic scientific library.
The journal is indexed by SCOPUS, Ulrich's International Periodicals Directory.
[Original research] [Clinical Pharmacology] [Pharmacology]
Dmitry Pozdnyakov; Ilya E. Rybalko; Kristina Khorenovna Sarkisyan;
Проведено изучение кардиопротекторной активности шести новых производных 3-формилхромона в сравнении с триметазидином и мельдонием при курсовом терапевтическом пероральном введении в условиях экспериментального инфаркта миокарда. Установлено, что применение производных 3-формилхромона увеличивает активность цитратсинтазы и соответственно метаболическую активность интерфибриллярных митохондрий, подавляя при этом образование супероксид-радикала в субсарколеммальных митохондриях, уменьшая зону некроза миокарда
References:
1. Poluektov Y. M., Petrushanko I. Y., Undrovinas N. A. Glutathione-related substances maintain cardiomyocyte contractile function in hypoxic conditions. Sci. Rep. 2019;9(1):4872. https://doi.org/10.1038/s41598-019-41266-2
2. Marzilli M., Vinereanu D., Lopaschuk G. Trimetazidine in cardiovascular medicine. Int. J. Cardiol. 2019;293:39-44. https://doi.org/10.1016/j.ijcard.2019.05.063
3. Schobersberger W., Dünnwald T., Gmeiner G., Blank C. Story behind meldonium-from pharmacology to performance enhancement: a narrative review. Br. J. Sports Med. 2017;51(1):22-25. https://doi.org/10.1136/bjsports-2016-096357
4. Kumar A. A., Kelly D. P., Chirinos J. A. Mitochondrial Dysfunction in Heart Failure With Preserved Ejection Fraction. Circulation. 2019;139(11):1435-1450. https://doi.org/10.1161/CIRCULATIONAHA.118.036259
5. Ribeiro Junior R. F., Dabkowski E. R, Shekar K. C., O’Connell K. A., Hecker P. A. MitoQ improves mitochondrial dysfunction in heart failure induced by pressure overload. Free Radic. Biol. Med. 2018;117:18-29. https://doi.org/10.1016/j.freeradbiomed.2018.01.012
6. Crochemore C., Mekki M., Corbière C. Subsarcolemmal and interfibrillar mitochondria display distinct superoxide production profiles. Free Radic. Res. 2015;49(3):331-337. https://doi.org/10.3109/10715762.2015.1006212
7. Sun J., Nguyen T., Aponte A. M. Ischaemic preconditioning preferentially increases protein S-nitrosylation in subsarcolemmal mitochondria. Cardiovasc. Res. 2015;106(2):227- 236. https://doi.org/10.1093/cvr/cvv044
8. Voronkov A. V., Pozdnyakov D. I., Rukоvitsyna V. M., Oganesyan E. T., Voronkova M. P. Cardiotropic properties of chromone-3-aldehyde derivatives under an experimental cardiac infarction complicated with hypercholesterolemia. Health Risk Analysis. 2019;3:128-134. https://doi.org/10.21668/health.risk/2019.3.15
9. Percie du Sert N., Hurst V., Ahluwalia A. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol. 2020;18(7):e3000410. https://doi.org/10.1371/journal.pbio.3000410
10. Demir D., Kuru Bektaşoğlu P., Koyuncuoğlu T. Neuroprotective effects of mildronate in a rat model of traumatic brain injury. Injury. 2019;50(10):1586-1592. https://doi.org/10.1016/j.injury.2019.08.036
11. Rukovitsina V. M., Pozdnyakov D. I., Chiryapkin A. S., Oganesyan E. T. Derivatives of 3-formylchromone as modulators of mitochondrial complex III activity. Vestnik Voronezhskogo gosudarstvennogo universiteta. Seriya: Khimiya. Biologiya. Farmatsiya. – Bulletin of the Voronezh State University. Series: Chemistry. Biology. Pharmacy. 2019;4:114-121. (In Russ.).
12. Long Q., Huang L., Huang K., Yang Q. Assessing Mitochondrial Bioenergetics in Isolated Mitochondria from Mouse Heart Tissues Using Oroboros 2k-Oxygraph. Methods Mol. Biol. 2019;1966:237-246. https://doi.org/10.1007/978-1-4939-9195-2_19
13. Kras K. A., Hoffman N., Roust L.R., Benjamin T. R., Filippis E. A., Katsanos C. S. Adenosine Triphosphate Production of Muscle Mitochondria after Acute Exercise in Lean and Obese Humans. Med. Sci. Sports Exerc. 2019;51(3):445- 453. https://doi.org/10.1249/MSS.0000000000001812
14. Zhu Z., Guo R., Li Y., Li S., Tu P. Comparison of three analytical methods for superoxide produced by activated immune cells. J. Pharmacol. Toxicol. Methods. 2020;101:106637. https://doi.org/10.1016/j.vascn.2019.106637
15. Wilcox X. E., Ariola A., Jackson J. R., Slade K. M. Overlap Concentration and the Effect of Macromolecular Crowding on Citrate Synthase Activity. Biochemistry.2020;59(18):1737-1746. https://doi.org/10.1021/acs.biochem.0c00073
16. Voronkov A. V., Pozdnyakov D. I., Rukovitsina V. M., Veselova O. F., Olokhova E. A., Oganesyan E. T. Antiradical and chelating properties of chromon-3-aldehyde derivatives. Eksperimentalnaya i klinicheskaya farmakologiya. – Experimental and clinical pharmacology. 2019;82(12):32-35. (In Russ.). https://doi.org/10.30906/0869-2092-2019-82-12-32-35
17. Pozdnyakov D. I., Voronkov A. V., Rybalko A. E. Chromone-3-aldehyde derivatives – sirtuin 2 inhibitors for correction of muscular dysfunction. Curr. Iss. Pharm. Med. Sci. 2019;32(1):45-50. https://doi.org/110.2478/cipms-2019-0010
18. van de Ven R. A. H., Santos D., Haigis M. C. Mitochondrial sirtuins and Molecular Mechanisms of Aging. Trends Mol. Med. 2017;23(4):320-331. https://doi.org/10.1016/j.molmed.2017.02.005
Keywords: myocardial infarction, 3-formylchromone derivatives, mitochondrial dysfunction, cardioprotection